Non-Cholesterol Sterol Levels Predict Hyperglycemia and Conversion to Type 2 Diabetes in Finnish Men

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Cederberg, Henna ^a   Gylling, Helena ^a,b   Miettinen, Tatu A ^b   Paananen, Jussi ^a   Vangipurapu, Jagadish ^a   Pihlajamäki, Jussi ^a   Kuulasmaa, Teemu ^a   Stančáková, Alena ^a   Smith, Ulf ^c   Kuusisto, Johanna ^a   Laakso, Markku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AVENASTEROL; CAMPESTEROL; CHOLESTANOL; CHOLESTENOL; CHOLESTEROL; DESMOSTEROL; GLUCOSE; INSULIN; LATHOSTEROL; SITOSTEROL; SQUALENE; STEROL; UNCLASSIFIED DRUG;

ABCG8 GENE; ADULT; ARTICLE; CHOLESTEROL SYNTHESIS; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; FINLAND; GENE; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID ABSORPTION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AREA UNDER CURVE; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERGLYCEMIA; INCIDENCE; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; STEROLS;

EID: 84879512627     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067406     Document Type: Article

References (26)

1. Adiels M, Olofsson SO, Taskinen MR, Borén J, (2006) Diabetic dyslipidaemia. Curr Opin Lipidol 17: 238-246.
2. Laakso M, Cederberg H, (2012) Glucose control in diabetes: which target level to aim for? J Intern Med 272: 1-12.
3. Sutherland WH, Scott RS, Lintott CJ, Robertson MC, Stapely SA, et al. (1992) Plasma non-cholesterol sterols in patients with non-insulin dependent diabetes mellitus. Horm Metab Res 24: 172-175.
4. Simonen PP, Gylling HK, Miettinen TA, (2002) Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care 25: 1511-1515.
5. Simonen P, Gylling H, Miettinen TA, (2008) The validity of serum squalene and non-cholesterol sterols as surrogate markers of cholesterol synthesis and absorption in type 2 diabetes. Atherosclerosis 197: 883-888.
6. Briones ER, Steiger DL, Palumbo PJ, O'Fallon WM, Langworthy AL, et al. (1986) Sterol excretion and cholesterol absorption in diabetics and nondiabetics with and without hyperlipidemia. Am J Clin Nutr 44: 353-361.
7. Gylling H, Hallikainen M, Pihlajamäki J, Simonen P, Kuusisto J, et al. (2010) Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study. 51: 2422-2427.
8. Stranberg TE, Salomaa V, Vanhanen H, Miettinen TA, (1996) Associations of fasting blood glucose with cholesterol absorption and synthesis in nondiabetic middle-aged men. Diabetes 45: 755-761.
9. Pihlajamäki J, Gylling H, Miettinen TA, Laakso M, (2004) Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men. J Lipid Res 45: 507-512.
10. Miettinen TA, Gylling H, (2000) Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis 153: 241-248.
11. Gylling H, Hallikainen M, Pihlajamäki J, Agren J, Laakso M, et al. (2004) Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absoption and insulin sensitivity. J Lipid Res 45: 1660-1665.
12. Berge KE, von Bergmann K, Lutjohann D, Guerra R, Grundy SM, et al. (2002) Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J Lipid Res 43: 486-494.
13. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, et al. (2002) Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 110: 671-680.
14. Teupser D, Baber R, Ceglarek U, Scholz M, Illig T, et al. (2010) Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet 3: 331-339.
15. Stancáková A, Javorský M, Kuulasmaa T, Haffner SM, Kuusisto J, et al. (2009) Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 58: 1212-1221.
16. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, et al. (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-3167.
17. Laakso M, Zilinskaite J, Hansen T, Boesgaard TW, Vänttinen M, et al. (2008) Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study. Diabetologia 51: 502-511.
18. Miettinen TA, (1988) Cholesterol metabolism during ketoconazole treatment in man. J Lipid Res 29: 43-51.
19. Abdul-Ghani MA, Matsuda M, Jani R, Jenkinson CP, Coletta DK, et al. (2008) The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance. Am J Physiol Endocrinol Metab 295: E401-E406.
20. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.
21. Aulchenko YS, Ripke S, Isaacs A, van Duijn CM, (2007) GenABEL: an R library for genome-wide association analysis. Bioinformatics 23: 1294-1296.
22. Chen WM, Abecasis GR, (2007) Family-based association tests for genomewide association scans. Am J Hum Genet 81: 913-926.
23. Matthan NR, Zhu L, Pencina M, D'Agostino RB, Schaefer EJ, et al. (2013) Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in framingham offspring study participants. JAHA 2: e005066.
24. International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32: 1327-1334.
25. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, et al. (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41: 56-65.
26. Lu Y, Feskens EJ, Boer JM, Imholz S, Verschuren WM, et al. (2010) Exploring genetic determinants of plasma total cholesterol levels and their predictive value in a longitudinal study. Atherosclerosis 213: 200-205.